- Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
Clinical trials
-
Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study -
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
The ABCD-Gene Prospective Study - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
EVOLVE-MI - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF) - Investigator
- Sandeep Grover
- Ages
- N/A
- Sexes
- All
-
SWAP 9 - Investigator
- Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial - Ages
- 30 Years - NA Years
- Sexes
- All
-
Dal-Gene-2 - Investigator
- Dominick J Angiolillo
- Ages
- 45 Years - 99 Years
- Sexes
- All